Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Humoral immune responses by prime-boost heterologous route immunizations with CTB-MPR649–684, a mucosal subunit HIV/AIDS vaccine candidate

31 Mar 2006

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Herpesvirus Infections and Treatments
Share to HIV Research and Treatment
Share to Immune Cell Function and Interaction

Source

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Identifiers

PMID: 16621185
DOI: 10.1016/j.vaccine.2006.03.045

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Humoral immune responses by prime-boost heterologous route immunizations with CTB-MPR649–684, a mucosal subunit HIV/AIDS vaccine candidatePMID 16621185Read ↗

Lessons from IAVI-006, a Phase I clinical trial to evaluate the safety and immunogenicity of the pTHr.HIVA DNA and MVA.HIVA vaccines in a prime-boost strategy to induce HIV-1 specific T-cell responses in healthy volunteersSemantic proximity Read ↗

Genetic heterologous prime–boost vaccination strategies for improved systemic and mucosal immunitySemantic proximity Read ↗

DNA priming and gp120 boosting induces HIV-specific antibodies in a randomized clinical trialSemantic proximity Read ↗

Comparison of homologous and heterologous prime-boost immunizations combining MVA-vectored and plant-derived VP2 as a strategy against IBDVSemantic proximity Read ↗

HIV/AIDS Vaccines: 2018.Semantic proximity Read ↗

Bispecific antibodies: Potential immunotherapies for HIV treatmentSemantic proximity Read ↗

Humoral and T-cell responses following MVA-BN booster vaccination against mpox virus clades Ib and IIbSemantic proximity Read ↗

Which Antibody Functions are Important for an HIV Vaccine?Semantic proximity Read ↗

Heterologous prime–boost vaccination with adenoviral vector and protein nanoparticles induces both Th1 and Th2 responses against Middle East respiratory syndrome coronavirusSemantic proximity Read ↗

Vaccines and immunology: elucidating immunity to HIV-1 and current prospects for AIDS vaccine development.Semantic proximity Read ↗

P19-57 LB. Gene-based vaccination protects against mucosal infection by a heterologous highly pathogenic SIV isolate in rhesus monkeysSemantic proximity Read ↗

Transmission-blocking vaccines: Uses and current status of developmentSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.